Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finasteride vs. Low-dose Flutamide vs. Placebo in Prostate Cancer (2F Trial)
NCT06601205Phase 3Completed
- Sponsor
- Ospedali Galliera
- Start
- Jan 2004
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of finasteride, flutamide in prostate cancer (PCa), sponsored by Ospedali Galliera. Started Jan 2004; status: completed.
02
Drugs
finasterideflutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06601205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06601205.